RE: Offer26 Jan 2019 13:15
The situation is pretty straightforward. If Medco are serious about wanting the SE Asian assets (and given they made an unsolicited approach in October 2018, they seem to be), they should make a fair and attractive offer, and maybe an offer for the SE Asian assets only. This then leaves Ophir free to monetise the rest of its portfolio at a later date.
Due to takeover rules Medco will not be able to bid again for another 6 months if Monday's deadline passes. I'd therefore be surprised to not see an improved offer for the sake of 5-10p (Β£40-80m) which I think is what is needed over and above 48.5p to get the BOD on side.